A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction

被引:5
|
作者
Truebel, Hubert [1 ,2 ,6 ,7 ]
Wuester, Sandra [3 ,7 ]
Boehme, Philip [6 ,7 ]
Doll, Hinnerk [7 ]
Schmied, Sven [4 ,5 ,7 ]
Szymanski, Jacek [4 ,5 ,7 ,9 ]
Langer, Thorsten [1 ,2 ,7 ,8 ]
Ostermann, Thomas [7 ]
Cysarz, Dirk [7 ]
Thuermann, Petra [4 ,5 ,7 ]
机构
[1] HELIOS Clin Wuppertal, Dept Pediat, Wuppertal, Germany
[2] Witten Herdecke Univ, Dept Pediat, Sch Med, Fac Hlth, Witten, Germany
[3] HELIOS Clin Schwelm, Dept Pediat, Schwelm, Germany
[4] HELIOS Clin Wuppertal, Philipp Klee Inst Clin Pharmacol, Wuppertal, Germany
[5] Witten Herdecke Univ, Dept Clin Pharmacol, Sch Med, Fac Hlth, Witten, Germany
[6] Bayer Pharma AG, Cardiovasc Res, Apratherweg 18, D-42096 Wuppertal, Germany
[7] Witten Herdecke Univ, Sch Med, Fac Hlth, Witten, Germany
[8] Univ Freiburg, Dept Neuropediat & Muscle Disorders, Ctr Pediat, Fac Med, Freiburg, Germany
[9] Med Ctr City Reg Aachen GmbH, Aachen, Germany
关键词
Upper airway obstruction; HELIOX; Work of breathing; Clinical proof-of-concept study; PULMONARY-DISEASE; OXYGEN; EXERCISE; PRESSURE; FLOW; MIXTURE;
D O I
10.1007/s00421-019-04116-7
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background Helium in oxygen (HELIOX) can relieve airway obstruction and lower the work of breathing because it increases the threshold at which turbulent gas flow is induced. Less turbulent and more laminar flow lowers the work of breathing. According to guidelines, the fraction of Helium in HELIOX should be maximized (e.g. to 79%). Here, we investigate whether HELIOX with less than 60% of Helium is able to relieve the sensation of dyspnea in healthy volunteers. Methods 44 volunteers underwent resistive loading breathing different gases (medical air and HELIOX with a fraction of 25%, 50% or 75% helium in oxygen) in a double-blinded crossover design. Subjects rated their degree of dyspnea (primary outcome parameter) and the variability of noninvasively measured systolic blood pressure was assessed. Results Dyspnea was significantly reduced by HELIOX-containing mixtures with a fraction of helium of 25% or more. Similarly, blood pressure variability was reduced significantly even with helium 25% during respiratory loading with the higher load, whereas with the smaller load an effect could only be obtained with the highest helium fraction of 75%. Conclusion In this clinical trial, HELIOX with less than 60% of helium in oxygen decreased the sensation of dyspnea and blood pressure variability, a surrogate parameter for airway obstruction. Therefore, higher oxygen fractions might be applied without losing the helium-related benefits for the treatment of upper airway obstruction.
引用
收藏
页码:1253 / 1260
页数:8
相关论文
共 50 条
  • [31] Prevention of Human Immunodeficiency Virus Breastmilk Transmission with Copper Oxide: Proof-of-Concept Study
    Borkow, Gadi
    Covington, Chandice Y.
    Gautam, Bibha
    Anzala, Omu
    Oyugi, Julius
    Juma, Meshack
    Abdullah, Mohamed S.
    BREASTFEEDING MEDICINE, 2011, 6 (04) : 165 - 170
  • [32] Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
    Depommier, Clara
    Everard, Amandine
    Druart, Celine
    Plovier, Hubert
    Van Hul, Matthias
    Vieira-Silva, Sara
    Falony, Gwen
    Raes, Jeroen
    Maiter, Dominique
    Delzenne, Nathalie M.
    de Barsy, Marie
    Loumaye, Audrey
    Hermans, Michel P.
    Thissen, Jean-Paul
    de Vos, Willem M.
    Cani, Patrice D.
    NATURE MEDICINE, 2019, 25 (07) : 1096 - +
  • [33] Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study
    Hiller, Jonathan G.
    Ismail, Hilmy M.
    Hofman, Michael S.
    Narayan, Kailash
    Ramdave, Shakher
    Riedel, Bernhard J.
    ANESTHESIA AND ANALGESIA, 2016, 123 (05): : 1325 - 1327
  • [34] Forward Static Optimization in Dynamic Simulation of Human Musculoskeletal Systems: A Proof-of-Concept Study
    Shourijeh, Mohammad S.
    Mehrabi, Naser
    McPhee, John
    JOURNAL OF COMPUTATIONAL AND NONLINEAR DYNAMICS, 2017, 12 (05):
  • [35] The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study
    Hadjidemetriou, Marilena
    McAdam, Sarah
    Garner, Grace
    Thackeray, Chelsey
    Knight, David
    Smith, Duncan
    Al-Ahmady, Zahraa
    Mazza, Mariarosa
    Rogan, Jane
    Clamp, Andrew
    Kostarelos, Kostas
    ADVANCED MATERIALS, 2019, 31 (04)
  • [36] Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine
    Barbolosi, Dominique
    Summer, Ilyssa
    Meille, Christophe
    Serre, Raphael
    Kelly, Antony
    Zerdoud, Slimane
    Bournaud, Claire
    Schvartz, Claire
    Toubeau, Michel
    Toubert, Marie-Elisabeth
    Keller, Isabelle
    Taieb, David
    ONCOTARGET, 2017, 8 (24) : 39167 - 39176
  • [37] Expiratory variability index (EVI) is associated with the severity of acute bronchial obstruction in small children: A proof-of-concept study
    Seppa, Ville-Pekka
    Turkalj, Mirjana
    Hult, Anton
    Vuljanko, Ivana Maloca
    Plavec, Davor
    Erceg, Damir
    Petkovic, Giorgie
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 (06) : 636 - 642
  • [38] Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study
    Teranen, Ville
    Nissinen, Samuli
    Roine, Antti
    Antila, Anne
    Siiki, Antti
    Vaalavuo, Yrjo
    Kumpulainen, Pekka
    Oksala, Niku
    Laukkarinen, Johanna
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Proof-of-Concept for Long-Term Human Endometrial Epithelial Organoids in Modeling Menstrual Cycle Responses
    Jiang, Yanyu
    Palomares, Arturo Reyes
    Munoz, Patricia
    Nalvarte, Ivan
    Acharya, Ganesh
    Inzunza, Jose
    Varshney, Mukesh
    Rodriguez-Wallberg, Kenny Alexandra
    CELLS, 2024, 13 (21)